231 related articles for article (PubMed ID: 36587385)
1. The Role of Epigenetics in Brain and Spinal Cord Tumors.
Park SH
Adv Exp Med Biol; 2023; 1394():119-136. PubMed ID: 36587385
[TBL] [Abstract][Full Text] [Related]
2. Emerging Epigenetic Therapies for Brain Tumors.
Kukreja L; Li CJ; Ezhilan S; Iyer VR; Kuo JS
Neuromolecular Med; 2022 Mar; 24(1):41-49. PubMed ID: 34677796
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
4. Understanding the epigenetic landscape and cellular architecture of childhood brain tumors.
Alencastro Veiga Cruzeiro G; Rota C; Hack OA; Segal R; Filbin MG
Neurochem Int; 2021 Mar; 144():104940. PubMed ID: 33333210
[TBL] [Abstract][Full Text] [Related]
5. Pharmaco-epigenomics: On the Road of Translation Medicine.
López-Camarillo C; Gallardo-Rincón D; Álvarez-Sánchez ME; Marchat LA
Adv Exp Med Biol; 2019; 1168():31-42. PubMed ID: 31713163
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.
Maury E; Hashizume R
Epigenetics; 2017 May; 12(5):353-369. PubMed ID: 28059591
[TBL] [Abstract][Full Text] [Related]
7. Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnostic.
Kumar R; Liu APY; Orr BA; Northcott PA; Robinson GW
Cancer; 2018 Nov; 124(21):4168-4180. PubMed ID: 30255939
[TBL] [Abstract][Full Text] [Related]
8. Compendium of aberrant DNA methylation and histone modifications in cancer.
Hattori N; Ushijima T
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
[TBL] [Abstract][Full Text] [Related]
9. The growing role of epigenetics in childhood cancers.
Panditharatna E; Filbin MG
Curr Opin Pediatr; 2020 Feb; 32(1):67-75. PubMed ID: 31895160
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.
Lambert MP; Herceg Z
Mol Oncol; 2008 Jun; 2(1):33-40. PubMed ID: 19383327
[TBL] [Abstract][Full Text] [Related]
11. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
Zhu Y; Lu H; Zhang D; Li M; Sun X; Wan L; Yu D; Tian Y; Jin H; Lin A; Gao F; Lai M
Clin Epigenetics; 2018; 10():30. PubMed ID: 29507648
[TBL] [Abstract][Full Text] [Related]
12. Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence.
Liao P; Ostrom QT; Stetson L; Barnholtz-Sloan JS
Neuro Oncol; 2018 Jun; 20(7):942-953. PubMed ID: 29432558
[TBL] [Abstract][Full Text] [Related]
13. An update on the epigenetics of glioblastomas.
Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
[TBL] [Abstract][Full Text] [Related]
14. Weighing ependymoma as an epigenetic disease.
Stuckert A; Bertrand KC; Wang P; Smith A; Mack SC
J Neurooncol; 2020 Oct; 150(1):57-61. PubMed ID: 32964355
[TBL] [Abstract][Full Text] [Related]
15. Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State.
Nagaraja S; Quezada MA; Gillespie SM; Arzt M; Lennon JJ; Woo PJ; Hovestadt V; Kambhampati M; Filbin MG; Suva ML; Nazarian J; Monje M
Mol Cell; 2019 Dec; 76(6):965-980.e12. PubMed ID: 31588023
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic profiling for the molecular classification of metastatic brain tumors.
Orozco JIJ; Knijnenburg TA; Manughian-Peter AO; Salomon MP; Barkhoudarian G; Jalas JR; Wilmott JS; Hothi P; Wang X; Takasumi Y; Buckland ME; Thompson JF; Long GV; Cobbs CS; Shmulevich I; Kelly DF; Scolyer RA; Hoon DSB; Marzese DM
Nat Commun; 2018 Nov; 9(1):4627. PubMed ID: 30401823
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms in paediatric brain tumours: regulators lose control.
Badodi S; Marino S
Biochem Soc Trans; 2022 Feb; 50(1):167-185. PubMed ID: 35076654
[TBL] [Abstract][Full Text] [Related]
18. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
19. Beyond genetics: Exploring the role of epigenetic alterations in breast cancer.
Prabhu KS; Sadida HQ; Kuttikrishnan S; Junejo K; Bhat AA; Uddin S
Pathol Res Pract; 2024 Feb; 254():155174. PubMed ID: 38306863
[TBL] [Abstract][Full Text] [Related]
20. Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma.
Johns DA; Williams RJ; Smith CM; Nadaminti PP; Samarasinghe RM
Clin Transl Med; 2024 Feb; 14(2):e1560. PubMed ID: 38299304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
